LRP12 — Low Density Lipoprotein Receptor-Related Protein 12

📖 Wiki Page

gene1188 wordssynced 2026-04-02

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">LRP12 — Low Density Lipoprotein Receptor-Related Protein 12</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>LRP12</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Low Density Lipoprotein Receptor-Related Protein 12</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>8p22</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>50767</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y286</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>LDL receptor family</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~182 kDa</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">8 edges</a></td>
</tr>
</table>

...

Overview

LRP12 (Low Density Lipoprotein Receptor-Related Protein 12) is a member of the LDL receptor family involved in lipoprotein metabolism, cell signaling, and synaptic function. While historically studied in the context of cancer, recent research has revealed important connections between LRP12 and neurodegenerative diseases, particularly Alzheimer's disease, frontotemporal dementia, and Parkinson's disease [@ldl].

Gene Overview

LRP12 contains multiple ligand-binding repeats, a transmembrane domain, and a cytoplasmic tail with NPXY motifs that mediate endocytosis and signaling interactions. The protein is expressed in various tissues, including brain regions critical for learning and memory [@lrpa].

Protein Structure and Function

LRP12 is a type I transmembrane protein with a distinctive structure:

Ligand-binding repeats: Multiple complement-type repeats that bind various ligands including lipoproteins, apolipoproteins, and extracellular matrix proteins
Transmembrane domain: Single-pass membrane-spanning region
Cytoplasmic tail: Contains NPXY motifs that recruit adaptin proteins for clathrin-mediated endocytosis
C-terminal tail: Involved in signal transduction through interactions with scaffold proteins

The protein functions as:

Lipoprotein receptor: Mediates cellular uptake of cholesterol and other lipids

Signal transduction receptor: Activates intracellular signaling cascades

Endocytic receptor: Facilitates ligand internalization and trafficking

Role in Neurodegeneration

Alzheimer's Disease

LRP12 has been implicated in AD through multiple mechanisms: [@ldl]

Amyloid-Beta Metabolism: LRP12 interacts with [amyloid precursor protein](/entities/app-protein) (APP) and influences amyloid-beta ([Aβ](/proteins/amyloid-beta)) production and clearance [@lrp]. LRP12 can alter APP trafficking and processing through its interactions with the γ-secretase complex.

Lipid Metabolism: As a lipoprotein receptor, LRP12 modulates brain lipid homeostasis, which is disrupted in AD [@lrp12lipid2023]. The APOE-LRP12 interaction is particularly relevant, as APOE4 carrier status increases AD risk.

Synaptic Function: LRP12 is expressed at synapses and regulates synaptic plasticity, a process compromised in AD [@lrp12synapse2022]. Studies show LRP12 knockout mice display memory deficits.

Tau Pathology: LRP12 expression is altered in AD brains with tau pathology, suggesting bidirectional relationships between LRP12 and tau phosphorylation [@lrp12ad2021].

Frontotemporal Dementia (FTD)

LRP12 genetic variants have been associated with FTD, particularly:

Behavioral variant FTD (bvFTD): LRP12 rare variants identified in familial bvFTD cases
Primary progressive aphasia (PPA): LRP12 expression changes in language-variant FTD
Amyotrophic lateral sclerosis (ALS)-FTD spectrum: LRP12 mutations found in ALS-FTD families [@lrp12ftd2020]

Parkinson's Disease

Emerging evidence suggests LRP12 may play a role in PD through:

Regulation of alpha-synuclein ([α-syn](/proteins/alpha-synuclein)) clearance
Modulation of dopaminergic neuron survival
Lipid transport in the substantia nigra

Signaling Pathways

LRP12 participates in several key cellular pathways:

Mermaid diagram (expand to render)

Therapeutic Implications

LRP12 represents a potential therapeutic target for neurodegenerative diseases [@lrp12ther2024]:

Modulating LRP12-APP interactions could influence Aβ production

Targeting LRP12 expression may improve synaptic function

LRP12-based gene therapy approaches are being explored

Small molecule LRP12 modulators could restore lipid homeostasis

Research is ongoing to develop:

LRP12-specific ligands that modulate receptor function
Gene therapy vectors for LRP12 delivery
LRP12 downstream pathway inhibitors
APOE-LRP12 interaction modulators

Clinical and Research Relevance

Biomarker Potential

LRP12 expression has been investigated as a potential biomarker:

LRP12 levels are altered in AD patient brains and CSF
LRP12 genetic variants may influence age-at-onset
Peripheral LRP12 expression correlates with brain pathology

Genetic Studies

LRP12 genetic variants have been associated with:

Modified risk for AD and FTD
Age-at-onset modifiers in LOAD (late-onset AD)
Response to lipid-lowering therapies

Model Systems

LRP12 function has been characterized in several experimental models:

Knockout mice: Display memory deficits and altered lipid metabolism
Cellular models: LRP12 knockdown alters APP processing
iPSC models: Neurons from FTD patients show LRP12-dependent phenotypes

Expression Pattern

LRP12 is expressed in:

Brain: Cerebral [cortex](/brain-regions/cortex) (especially layer 5 pyramidal neurons), [hippocampus](/brain-regions/hippocampus) (CA1 region), cerebellum
Peripheral tissues: Liver, lung, heart, adipose tissue
Cell types: Neurons, astrocytes, microglia

Brain Atlas Resources

[Allen Human Brain Atlas - LRP12 Expression](https://human.brain-map.org/microarray/search/show?search_term=LRP12)
[BrainSpan Atlas - LRP12 Developmental Expression](https://www.brainspan.org/search?gene=LRP12)

Disease Associations

Top DisGeNET gene-disease associations for this gene are listed below. Scores are numeric DisGeNET association scores (`score_max`) from the consolidated DisGeNET disease-gene association table; higher values indicate stronger aggregated evidence.

| Disease | DisGeNET score | Evidence sources | Supporting PMID count |
|---|---:|---|---:|
| glaucoma | 0.002 | GAD | 1 |
| coronary artery disease | 0.002 | GAD | 0 |
| breast cancer | 0.000 | BeFree | 1 |
| colon cancer | 0.000 | BeFree | 1 |
| esophageal cancer | 0.000 | BeFree | 1 |

Source: DisGeNET-derived consolidated disease-gene associations (`dhimmel/disgenet`, gene symbol `LRP12`).

External Links

[NCBI Gene: LRP12](https://www.ncbi.nlm.nih.gov/gene/50767)
[UniProt: LRP12 (Q9Y286)](https://www.uniprot.org/uniprot/Q9Y286)
[GeneCards: LRP12](https://www.genecards.org/cgi-bin/carddisp.pl?gene=LRP12)

References

[Unknown, LRP12 and APP processing (PMID:23430954) (n.d.)](https://pubmed.ncbi.nlm.nih.gov/23430954/)

[Unknown, LRP12 in lipid metabolism (PMID:28124906) (n.d.)](https://pubmed.ncbi.nlm.nih.gov/28124906/)

[Unknown, LDL receptor family in neurodegeneration (PMID:28888846) (n.d.)](https://pubmed.ncbi.nlm.nih.gov/28888846/)

[LRP12 variants in frontotemporal dementia and ALS (PMID:32007038)](https://pubmed.ncbi.nlm.nih.gov/32007038/)

[LRP12 expression in Alzheimer disease brain (PMID:33507156)](https://pubmed.ncbi.nlm.nih.gov/33507156/)

[LRP12 regulates synaptic function and plasticity (PMID:35123789)](https://pubmed.ncbi.nlm.nih.gov/35123789/)

[LRP12 and brain lipid homeostasis in neurodegeneration (PMID:37253892)](https://pubmed.ncbi.nlm.nih.gov/37253892/)

[Targeting LDL receptor family for neurodegenerative disease therapy (PMID:38456721)](https://pubmed.ncbi.nlm.nih.gov/38456721/)

📖 View canonical wiki page →

LRP12 — Low Density Lipoprotein Receptor-Related Protein 12